Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs Global X Robotics and Artificial Intelligence ETF (BOTZ) Price & Performance

Amylx Pharmaceuticals IncTrade
Global X Robotics and Artificial Intelligence ETFTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Global X Robotics and Artificial Intelligence ETF — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Global X Robotics and Artificial Intelligence ETF trades at $37.81. The key difference: Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Global X Robotics and Artificial Intelligence ETF nearer its low. Which is the better fit depends on your goals.

AMLXBOTZ
Market Cap
$2.64B
Sector
Health
52-Week High
$24.19$41.63
52-Week Low
$7.82$31.99
Enterprise Value
$2.39B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About Global X Robotics and Artificial Intelligence ETF

The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that are involved in the development of robotics and/or artificial intelligence. The fund is non-diversified.

Read more on BOTZ